ResMed Inc. (RMD) New York Stock Exchange
112.78-0.65-0.57%
CloseMay 17, 2019

News: updated – 20-May 04:33


Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought19-May 03:15(Business Wire)

Million-patient study reveals gaps in long-term therapy adherence among various sub-populations Study helps sleep specialists identify which populations generally need more clinical support ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors …